Patent details

EP2134364 Title: TREATMENT OF CARCINOMAS WITH A COMBINATION OF EGF-PATHWAY AND TELOMERASE INHIBITORS

Basic Information

Publication number:
EP2134364
PCT Application Number:
PCT/US/2008/003001
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP087265187
PCT Publication Number:
WO/2008/112129
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF CARCINOMAS WITH A COMBINATION OF EGF-PATHWAY AND TELOMERASE INHIBITORS
French Title of Invention:
TRAITEMENT DE CARCINOMES AVEC UNE COMBINAISON D'INHIBITEURS DE VOIE EGF ET DE TELOMERASE
German Title of Invention:
BEHANDLUNG VON KARZINOMEN MIT EINER KOMBINATION AUS EGF-PFAD- UND TELOMERASE-HEMMERN
SPC Number:

Dates

Filing date:
06/03/2008
Grant date:
13/02/2013
EP Publication Date:
13/02/2013
PCT Publication Date:
18/09/2008
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/12/2009
EP B1 Publication Date:
13/02/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/03/2013
Expiration date:
06/03/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/03/2008
 
 

Name:
Geron Corporation
Address:
149 Commonwealth Drive, Menlo Park, CA 94025, United States (US)

Inventor

1

Name:
TRESSLER Robert, J.
Address:
United States (US)

2

Name:
GO Ning
Address:
United States (US)

Priority

Priority Number:
905944 P
Priority Date:
09/03/2007
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;
Filing date Document type Number of pages